Japan: Opportunities in Japan’s Life Science market
Japan’s pharmaceutical and medical device markets are among the largest in the world worth 77 and 37 billion USD respectively and growing at about 0,5 % and 3 % per year. This is a market of major importance to established Swedish pharmaceutical and medical device companies. The Japanese market is highly relevant to most Swedish companies in the industry. The backbone of the market is Japan’s comprehensive compulsory healthcare insurance system financed by insurance premiums, co-payments (typically 10 to 30 %) and taxes.